10x Genomics: Leerink Partners raises target price to $90 from $40
TXG•Leerink Partners raised its target price for 10x Genomics to $90 from $40.
Related News
Palantir CTO Shyam Sankar reports $64.93 million common share sale
PLTR•
Nasdaq trade halt continues, news pending at 03:28 a.m.
CARY•
Oportun presents strategy for disciplined new member growth
OPRT•
Microsoft says no indication FAA ground stop is related to its services
MSFT•
Kratos Defense & Security Solutions US division president Steven S. Fendley sells $473,832.80 in common shares
KTOS•